Catalent Pharma Solutions | 31-Aug-2015
| Technical / White Paper
According to the National Organization for Rare Disorders (NORD), a disease is rare if it affects fewer than 200,000 Americans. Big Pharma used to ignore...
World Courier | 21-Jul-2015
| Technical / White Paper
Going green is moving from a clichéd corporate phrase to simply the way business is run. Companies around the globe continue to make significant investments...
Billions of patients worldwide benefit from a diverse range of medical devices. The global medical device market in 2011 was approximately $300 billion...
Trimming your study budget is a good thing, right? When you can cut costs without compromising data integrity or accuracy, that's usually a positive....
Tubing used in biopharmaceutical applications has particular requirements. Among them are the ability to withstand sterilization processes, the delivery...
Download World Courier’s latest piece which shares the story of the changes in temperature-controlled transport and what these trends mean to your business....
Norwich Pharmaceuticals Inc | 15-Jun-2015
| Technical / White Paper
As the pharmaceutical industry moves to more potent APIs and complex delivery systems, the need to work with solvents is increasing. This white paper discusses...
AdvantaPure® | 08-Jun-2015
| Technical / White Paper
Pharmaceutical fluid transfer involves many tubing-to-fitting connections, and unfortunately those connections can leak and result in contamination, production...
ACM Global Central Laboratory | 19-May-2015
| Clinical Study
Until recently, sponsors and CROs engaged their central laboratory simply for routine safety testing. However, as clinical trial protocols have grown in...
Myths abound about global transport. You hear people talking about them at conferences (normally in the coffee queue or in the quiet few moments as they...
Butterworth | 12-May-2015
| Technical / White Paper
Samplestorage, handling anddelivery are as important in the determination of residual solvents as the analysis itself. This paper provides practical advice...
Today, many pharmaceutical companies are choosing the 505(b)(2) New Drug Approval (NDA) regulatory pathway. The 505(b)(2) NDA route relies on investigations...
It’s no secret that drug development has undergone explosive global growth over the last decade. Maybe it is because of the pace of change that some old...
SGS Life Science Services | 20-Apr-2015
| Technical / White Paper
Within the pharmaceutical industry, there are six dominant methods used to model outsourcing strategy. This white paper details how a hybrid strategy can...
Merge eClinical | 01-Apr-2015
| Technical / White Paper
Intense competition in the prescription drug market is driving pharmaceutical companies to expedite their drug discovery and development processes. Pharmaceutical...
